Davis Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$73.2K Buy
61
+48
+369% +$49K 0.04% 135
2026
Q1
$12K Hold
13
0.01% 209
2025
Q4
$14K Sell
13
-11
-46% -$10.5K 0.01% 210
2025
Q3
$18.3K Buy
+24
New +$17.9K 0.01% 194
2025
Q1
$13.2K Hold
16
0.01% 206
2024
Q4
$12.4K Sell
16
-100
-86% -$82.8K 0.01% 208
2024
Q3
$103K Buy
116
+5
+5% +$4.5K 0.08% 98
2024
Q2
$101K Buy
111
+11
+11% +$8.8K 0.09% 97
2024
Q1
$76.1K Hold
100
0.07% 104
2023
Q4
$58.3K Buy
+100
New +$58.4K 0.06% 114
2020
Q2
$16K Hold
100
0.03% 170
2020
Q1
$14K Buy
+100
New +$13.7K 0.03% 171

Other funds holding LLY

Davis Capital Management's LLY Position: Q2 2026 in Review

Davis Capital Management increased its Eli Lilly (LLY) stake by 369% in Q2 2026, buying an estimated $49K and bringing the position to 61 shares worth $73.2K. The position accounts for 0.04% of the portfolio, ranked #135.

Davis Capital Management first reported a position in LLY in Q1 2020 and has held it in 12 quarters since. The position peaked at $103K in Q3 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Davis Capital Management held 61 shares of Eli Lilly worth $73.2K as of Q2 2026.
  • Davis Capital Management bought 48 Eli Lilly shares in Q2 2026, an estimated $49K.
  • Eli Lilly made up 0.04% of Davis Capital Management's portfolio in Q2 2026, its #135 holding.
  • Davis Capital Management first reported a position in Eli Lilly in Q1 2020 and has held it in 12 quarters since.
  • Davis Capital Management's Eli Lilly position peaked at $103K in Q3 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Davis Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.